Cancer and deprescribing antithrombotic therapy at end-of-life research hub

Barriers and facilitators to deprescribing antithrombotic therapy in advanced cancer patients: A qualitative interview study of patients’, companions’ and clinicians’ experiences and perspectives

This study looks at how people with advanced cancer feel about taking blood-thinning medicines. Researchers want to understand patients' and carers' views on whether and when to stop these treatments. Taking part involves a single 30 to 60-minute interview. The findings will help build a new decision-making app for future patients.